ABSTRACT:
Indole containing molecules span plant, fungal, microbial and marine natural products as well as synthetic compounds used to interrogate biological systems. Yet reviews often treat natural-product chemistry, synthetic access, sustainability and pharmacological validation as separate topics, making it difficult to prioritize which scaffolds should be isolated, synthesized or redesigned. This review proposes a nature to laboratory framework that connects (i) the biosynthetic origin and structural class of indole metabolites, (ii) the synthetic transformations that provide access to natural products and analogues, (iii) sustainability metrics for comparing routes, and (iv) an evidence ladder for judging biological claims and translational readiness. Representative classes including tryptophan-derived metabolites, monoterpenoid indole alkaloids, indole diterpenes, phytoalexins and marine indole alkaloids are considered alongside classical annulations, C-H functionalization, asymmetric catalysis, electrochemical methods and engineered biosynthesis. A critical synthesis of the literature identifies recurring gaps: inconsistent reporting of yields and biological endpoints, limited head to head comparison of natural and synthetic analogues, underuse of quantitative green chemistry metrics, and insufficient linkage between structural identity, assay quality and ADME toxicity. Rather than claiming an unverified first ever topic, the article’s novelty lies in a practical, cross-disciplinary decision framework for selecting indole leads and designing the next experiment. The framework is intended to support medicinal chemists, natural-product researchers and synthetic chemists in moving from structural diversity to reproducible, sustainable and testable hypotheses.